- Home
- STRO vs NECB Comparison
STRO vs NECB Comparison
Compare STRO & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STRO | NECB |
|---|---|---|
| Founded | 2003 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.8M | 368.0M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | STRO | NECB |
|---|---|---|
| Price | $16.91 | $26.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $31.33 | $30.00 |
| AVG Volume (30 Days) | ★ 207.3K | 30.5K |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.12% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.46 |
| Revenue | ★ $38,419,000.00 | N/A |
| Revenue This Year | N/A | $4.85 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | ★ N/A | $18.36 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $19.27 |
| 52 Week High | $43.85 | $28.94 |
Technical Indicators
Market Signals| Indicator | STRO | NECB |
|---|---|---|
| Relative Strength Index (RSI) | 26.11 | 52.13 |
| Support Level | $10.34 | $25.87 |
| Resistance Level | $17.33 | $27.53 |
| Average True Range (ATR) | 0.99 | 0.44 |
| MACD | -0.24 | 0.03 |
| Stochastic Oscillator | 9.16 | 66.77 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States, including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.